Some early-phase clinical trials have been mentioned in the literature
You should speak with us first if you: Are pregnant or breastfeeding Have certain medical conditions Are taking specific medications We will always ensure the treatment is appropriate for you
Indications for amlodipine include left ventricular hypertrophy, asymptomatic atherosclerosis, angina pectoris, vasospastic angina, peripheral artery disease, metabolic syndrome, and, in the elderly, isolated systolic hypertension 18,19,20
Positive topline results from the Phase III SYNCHRONIZE-1 obesity trial of survodutide
This rebound likely reflects recovery of mevalonate intermediates and mitochondrial acetyl-CoA flux, consistent with improved bioenergetics
Fosgonimeton failed its Phase 2 ACT-AD trial in 2022 and its Phase 2/3 LIFT-AD trial in September 2024